Concepedia

Joel Johansson

JJ

Statistics

Publications

8

Citations

278

H-Index

8

Active since

2013

Affiliations

Cancer Research UK Scotland Institute(Current)

University of Glasgow

Karolinska Institutet

Novartis Institutes for BioMedical Research

Linköping University Hospital

Joel Johansson is an author at Cancer Research UK Scotland Institute specializing in oncology, signal transduction, and medicine.

ORCID

Publications per year

2013–2021

8

Publications

8

TGF-β1-Induced Epithelial–Mesenchymal Transition Promotes Monocyte/Macrophage Properties in Breast Cancer Cells

Joel Johansson, Vedrana Tabor, Anna Wikell et al. · Frontiers in Oncology · 2015 · 71 citations · Full text

, , +16

RAL GTPases Drive Intestinal Stem Cell Function and Regeneration through Internalization of WNT Signalosomes

Joel Johansson, Máté Nászai, Michael C. Hodder et al. · Cell stem cell · 2019 · 65 citations · Full text

, , +17

CXADR-Mediated Formation of an AKT Inhibitory Signalosome at Tight Junctions Controls Epithelial–Mesenchymal Plasticity in Breast Cancer

Azadeh Nilchian, Joel Johansson, Aram Ghalali et al. · Cancer Research · 2018 · 46 citations · Full text

, , +17

A RAC-GEF network critical for early intestinal tumourigenesis

Karen Pickering, Kathryn Gilroy, Jordan Cassidy et al. · Nature Communications · 2021 · 27 citations · Full text

, , +16

C/EBPβ expression is an independent predictor of overall survival in breast cancer patients by MHCII/CD4-dependent mechanism of metastasis formation

Ewa Kurzejamska, Joel Johansson, Karin Jirström et al. · Oncogenesis · 2014 · 24 citations · Full text

, , +16

1–5 of 8